Perrigo Company plc (PRGO) Financials

PRGO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 8.0 billion 5.5 billion
Dec. 31, 2025 8.5 billion 5.6 billion
Sept. 30, 2025 10.1 billion 5.6 billion
June 30, 2025 10.1 billion 5.6 billion

PRGO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -127.4 million 14.4 million
Dec. 31, 2025 148.6 million 13.0 million
Sept. 30, 2025 29.8 million 13.2 million
June 30, 2025 56.7 million 16.8 million

PRGO Net Income

No data available :(

PRGO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 357.2 million 3.6 billion 157.5 million
Dec. 31, 2025 531.6 million 3.7 billion 163.0 million
Sept. 30, 2025 432.1 million 3.6 billion 164.2 million
June 30, 2025 454.2 million 3.6 billion 163.6 million

PRGO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 138.7 million
Dec. 31, 2025 138.5 million
Sept. 30, 2025 138.9 million
June 30, 2025 138.2 million

PRGO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 13.8 million 24.6 million 129.7 million 129.7 million
Dec. 31, 2025 26.8 million 21.8 million -249.3 million 70.1 million
Sept. 30, 2025 21.9 million 24.9 million 221.5 million 127.3 million
June 30, 2025 19.2 million 22.0 million 273.1 million 160.1 million

PRGO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 969.2 million 643.7 million
Dec. 31, 2025 1.1 billion 747.4 million
Sept. 30, 2025 1.0 billion 666.2 million
June 30, 2025 1.1 billion 693.4 million

PRGO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PRGO

List: Contenders

Price: $10.47

52 week price:
9.23
28.44

Dividend Yield: 10.60%

5-year range yield:
2.16%
10.60%

Forward Dividend Yield: 10.95%

Payout Ratio: -133.01%

Payout Ratio Range:
-1425.00%
1880.00%

Dividend Per Share: 1.16 USD

Earnings Per Share: -12.93 USD

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Ireland

Volume: 680000

Ebitda: 274.7 million

Market Capitalization: 1.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 24

DGR3: 6.74%

DGR5: 8.31%

DGR10: 10.96%

DGR20: 11.24%

Links: